Skip to main content

Centiva Capital, LP

Position in ROIV — Roivant Sciences Ltd.

CIK 1692507 New York, NY

Position in ROIV

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$210,409
+$210,409 QoQ
Shares Held
7,596
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Derivatives in ROIV

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$692,500
PutShares
25,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Centiva Capital, LP holds $32,694,585 across 26 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ROIV

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $210,409 7,596
2026-03-31 $692,500 25,000
2025-12-31 $4,774,000 220,000
2025-12-31 $10,003,700 461,000
2025-09-30 $6,974,930 461,000
2025-09-30 $3,328,600 220,000
2025-06-30 $4,281,473 379,900
2025-06-30 $225,400 20,000
2024-06-30 $317,459 30,034
2024-03-31 $1,684,260 159,797
2023-12-31 $59,058 5,259
2023-12-31 $2,246,000 200,000
2023-09-30 $583,696 49,974
2022-09-30 $501,109 155,624
2022-06-30 $2,056,123 505,190
2022-03-31 $1,820,370 368,496